Patent · US Active

Treatment of Fuchs' endothelial corneal dystrophy

US11512312B2 · kind B2 · utility

0Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 9, 2018
Grant dateNov 29, 2022
Priority date—
Expiry dateMar 9, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described are compounds and methods useful in the treatment of Fuchs' Endothelial Corneal Dystrophy (FECD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.